Ignite Creation Date:
2025-12-26 @ 12:15 PM
Ignite Modification Date:
2026-02-25 @ 9:41 PM
Study NCT ID:
NCT00544700
Status:
TERMINATED
Last Update Posted:
2020-02-20
First Post:
2007-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
Sponsor:
Swiss Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SAKK 41/06
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None